Since 2021, there’s been an increase in representation of people from underrepresented and underserved communities in Super ...
The Super Bowl has always been more than a game—it’s a cultural barometer, reflecting how brands engage with audiences at the ...
Create diverse, relevant, ethical and socially-aware brands for clients, corporations, communities and cultures. MA Graphic Branding and Identity will help you go beyond visual identity, typographical ...
In this article, we are going to take a look at where Novartis AG (NYSE:NVS) stands against the other foreign stocks. In August, S&P Global Market Intelligence reported that US dividends are set ...
According to iSpot.TV’s analysis of January TV drug ad spending data, Novartis’ prostate cancer drug Pluvicto swooped in to take the No. 1 spot on the list, with more than $47 million spent ...
Excluding the heart failure drug Entresto, which will lose its patent in mid-2025, the Novartis brand portfolio grew about 38%. This led the company to offer a 5% plus sales guidance until 2029 ...
We recently compiled a list of the 10 Best Foreign Stocks With Dividends For Passive Income. In this article, we are going to take a look at where Novartis AG (NYSE:NVS) stands against the other ...
Novartis AG (NYSE:NVS ... brand NBRx post the approval in early breast cancer and the positive NCCN guidelines. The brand grew 65% in the U.S. in quarter four. We have metastatic share at 50% ...
CEO Vas Narasimhan highlighted Novartis' strong performance in Q4 2024 ... driven by new launches in HS and IV formulations. The brand remains a leader in the IL-17 category across key markets.